You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2022 R33 CA269094 CA21-004 MOELLERING, RAYMOND E UNIVERSITY OF CHICAGO Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues Active
2007 R33 CA122900 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2014 R33 CA177449 RFA-CA-13-002 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2017 R33 CA212806 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells NCE
2001 R33 CA083234 PAR-98-067 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER Complete
2013 R33 CA173300 RFA-CA-12-003 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES Complete
2019 R33 CA225549 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2002 R33 CA095957 PAR-01-104 BEACHY, PHILIP A JOHNS HOPKINS UNIVERSITY GENOME-BASED TARGETING OF THE HEDGEHOG PATHWAY IN CANCER Complete
2018 R33 CA228979 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2007 R33 CA128726 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2014 R33 CA181771 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2017 R33 CA212968 RFA-CA-16-002 SINGH, ANKUR CORNELL UNIVERSITY LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics Complete
2001 R33 CA083230 PAR-98-067 WIND, ROBERT A BATTELLE PACIFIC NORTHWEST LABORATORIES INTEGRATED OPTICAL/MAGNETIC RESONANCE MICROSCOPY Complete
2013 R33 CA173264 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 CA196445 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2012 R33 CA173382 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2019 R33 CA229042 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2002 R33 CA097541 PAR-01-104 WAGGONER, ALAN S CARNEGIE-MELLON UNIVERSITY NEAR IR FLUORESCENT PROBES/MOLECULAR ANALYSIS OF CANCER Complete
2018 R33 CA229023 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2014 R33 CA183671 RFA-CA-13-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA MULTIPLEXED KINASE BIOSENSOR TECHNOLOGY TO DETECT LEUKEMIA SIGNALING WITH MASS SP Complete
2017 R33 CA212973 RFA-CA-16-002 YATES, JOHN R SCRIPPS RESEARCH INSTITUTE Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry Complete
2021 R21 CA261734 CA20-019 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA Novel cryopreservation method for stabilization of manufactured therapeutic cells Completed
1999 R21 CA081674 PAR-98-067 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY REPRESENTATIONAL APPROACHES TO GENOMIC ANALYSIS Complete
2007 R21 CA126667 RFA-CA-07-002 MINDERMAN, HANS ROSWELL PARK CANCER INSTITUTE CORP CLINICAL APPLICATION OF MULTISPECTRAL IMAGING FLOW CYTOMETRY Complete
2006 R21 CA123329 RFA-CA-06-003 WANG, BINGHE GEORGIA STATE UNIVERSITY MRI CONTRAST AGENTS TARGETING CARBOHYDRATE BIOMARKERS Complete
2009 R21 CA137694 RFA-CA-08-006 TANNER, SCOTT DAVID UNIVERSITY OF TORONTO DEVELOPMENT OF (PROTOTYPE) BEAD ARRAY FLOW CYTOMETER WITH MASS SPECTROMETER DETEC Complete
2016 R21 CA202875 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2000 R21 CA083241 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2005 R21 CA111994 RFA-CA-05-004 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION Complete
2008 R21 CA125336 RFA-CA-07-035 NOLTE, DAVID D PURDUE UNIVERSITY WEST LAFAYETTE MULTIPLEXED ASSAYS ON THE BIOCD FOR ACUTE LYMPHOCYTIC LEUKEMIA Complete
2011 R21 CA157366 RFA-CA-10-005 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE TARGETING CANCER CELLS WITH FUNCTIONALIZED NANOPARTICLE LIBRARIES Complete
2015 R21 CA196468 RFA-CA-14-005 KRUMMEL, MATTHEW F UNIVERSITY OF CALIFORNIA, SAN FRANCISCO LIVING TUMOR BIOPSIES TO INTERROGATE IMMUNE FUNCTION AND RESPONSE TO THERAPY Complete
2018 R21 CA229037 RFA-CA-17-012 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing Active
2021 R21 CA261737 CA20-019 HAINER, SARAH JANE UNIVERSITY OF PITTSBURGH AT PITTSBURGH Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN Completed
1999 R21 CA081732 PAR-98-067 STRAUSS, WILLIAM M BETH ISRAEL DEACONESS MEDICAL CENTER EVALUATION OF SEQUENCE SPECIFIC CHANGES IN GENOMIC DNA Complete
2007 R21 CA125337 RFA-CA-07-002 KAUFMAN, DAVID G. UNIV OF NORTH CAROLINA CHAPEL HILL IDENTIFICATION OF AREAS OF OXIDATIVE DAMAGE IN HUMAN GENOMIC DNA Complete
2020 R21 CA240185 RFA-CA-19-019 LI, WEI TEXAS TECH UNIVERSITY Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip Active
2006 R21 CA123018 RFA-CA-06-003 SHI, HUIDONG UNIVERSITY OF MISSOURI-COLUMBIA EPIGENETIC TARGETING IN NON-HODGKIN'S LYMPHOMA Complete
2009 R21 CA137707 RFA-CA-08-006 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROASSAY SYSTEMS FOR DIAGNOSIS OF CANCER CELL MOTILITY AND METASTASIS Complete
2016 R21 CA202831 RFA-CA-15-002 LIANG, FU-SEN UNIVERSITY OF NEW MEXICO NOVEL BI-FUNCTIONAL INHIBITORS BLOCKING ONCOMIR BIOGENESIS Complete
2000 R21 CA088197 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete
2005 R21 CA114167 RFA-CA-05-004 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) DEVELOPMENT OF AN AUTOMATED FROZEN SAMPLE ALIQUOTTER Complete
2008 R21 CA126733 RFA-CA-07-037 WONG, DAVID T UNIVERSITY OF CALIFORNIA LOS ANGELES COLLECTION, STABILIZATION AND STORAGE OF SALIVA SAMPLES FOR CANCER RESEARCH Complete
2011 R21 CA128692 RFA-CA-10-005 CLARY, BRYAN M DUKE UNIVERSITY IN VIVO SELECTION OF TUMOR-SPECIFIC RNA BINDING MOTIFS Complete
2018 R21 CA225507 RFA-CA-17-012 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome NCE
2022 R21 CA269103 CA21-003 BLAINEY, PAUL CLARK BROAD INSTITUTE, INC. Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout Active
2021 R21 CA263147 CA20-017 BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN Spectroscopy Assisted Laser Microdissection Completed
1999 R21 CA081668 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2007 R21 CA116127 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2020 R21 CA247638 RFA-CA-19-019 LIANG, FU-SEN CASE WESTERN RESERVE UNIVERSITY Spatiotemporal Epitranscriptome Editing Technology Active

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®